Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Asthma and exercise].

J Lecomte1

  • 1Service de Médecine du Sport et de Pneumologie, C.H.U. de Charleroi, Site de Charleroi, U.L.B.

Revue Medicale De Bruxelles
|November 9, 2002
PubMed
Summary
This summary is machine-generated.

Exercise-induced asthma (EIA) causes breathing difficulties after exercise. Management includes medication, warm-ups, and protective gear, with training potentially improving symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2002
Same author

A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2002
Same author

A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.

British journal of cancer·2001
Same author

Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.

Cancer·2000
Same author

A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. The European Lung Cancer Working Party. 101473.1044@compuserve.com.

Lung cancer (Amsterdam, Netherlands)·2000
Same author

Evaluation of autoantibodies against oxidized LDL and antioxidant status in top soccer and basketball players after 4 months of competition.

Free radical biology & medicine·2000
Same journal

[Breast cancer screening : a tool for informed decision making].

Revue medicale de Bruxelles·2018
Same journal

[Breast cancer screening : present situation and prospects].

Revue medicale de Bruxelles·2018
Same journal

[Guidelines in medical imaging : objectives, limits and radiation protection].

Revue medicale de Bruxelles·2018
Same journal

[How to avoid overmedicalization of the elderly patient ?]

Revue medicale de Bruxelles·2018
Same journal

[Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention].

Revue medicale de Bruxelles·2018
Same journal

[New strategies in specific care for benign prostatic hypertrophy in older men].

Revue medicale de Bruxelles·2018
See all related articles

Area of Science:

  • Pulmonary Medicine
  • Sports Medicine
  • Allergy and Immunology

Context:

  • Exercise-induced asthma (EIA) is a common condition affecting both the general population and athletes.
  • Symptoms like wheezing and shortness of breath typically appear 5-15 minutes post-exercise.
  • Prevalence estimates range from 7-15% in the general population and 3-14% in athletes.

Purpose:

  • To define exercise-induced asthma (EIA), its triggers, and prevalence.
  • To explore the underlying mechanisms, including hyperventilation and airway fluid changes.
  • To review current and alternative therapeutic strategies and preventative measures.

Summary:

  • EIA is characterized by bronchoconstriction post-exercise, influenced by exercise intensity and duration.

Related Experiment Videos

  • Hyperventilation and airway hypertonicity are key stimuli, leading to mediator release.
  • Current treatments include beta-agonists and disodium cromoglycate, with antileukotrienes as alternatives.

    • Impact:

    • Understanding EIA mechanisms aids in developing targeted therapies.
    • Preventative strategies like warm-ups and protective gear can mitigate symptoms.
    • Regular training may improve exercise tolerance and overall well-being for individuals with EIA.